About this trial
The evolution of systemic microvascular reactivity may aid in the comprehension of cardiovascular physiology in heart transplantation patients, and possibly suggest the non-invasive evaluation of skin microcirculation as an ancillary tool in the clinical evaluation of these patients.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
capability to understand the objectives of the research and to fulfill the Term of Consent
Disqualifiers
Pregnancy, acute infection diagnosis, use of circulatory assistance devices
Trial population
adult individuals from the cohort of heart failure patients under evaluation for heart transplantation, at the National Institute of Cardiology, Rio de Janeiro, Brazil
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
skin microvascular reactivity
Diagnostic testLaser-based method for evaluating non-invasive, operator-independent systemic microvascular function that detects microvascular flow in the skin for the evaluation of systemic vascular endothelial function.
Treatment groups
Trial outcomes
Primary outcomes
Baseline and post-iontophoresis of acetylcholine endothelium-dependent skin microvascular reactivity
Evaluation of systemic microvascular reactivity induced by endothelium-dependent agents. Microvascular reactivity will be evaluated using a non-invasive and operator -independent methodology, named laser speckle contrast imaging, coupled with skin iontophoresis of vasodilator agents. Cutaneous microvascular flow will be measured in arbitrary perfusion units, divided by mean arterial pressure, to yield cutaneous vascular conductance.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.